SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-053262
Filing Date
2021-10-18
Accepted
2021-10-18 15:32:35
Documents
5
Effectiveness Date
2021-10-18

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea148963-s8_inmedphar.htm S-8 58655
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP REGARDING LEGALITY OF SECURITIES BEI ea148963ex5-1_inmedphar.htm EX-5.1 12608
3 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea148963ex23-1_inmedphar.htm EX-23.1 3642
4 GRAPHIC ex5-1_001.jpg GRAPHIC 14115
5 GRAPHIC ex23-1_001.jpg GRAPHIC 6374
  Complete submission text file 0001213900-21-053262.txt   104412
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-260323 | Film No.: 211328228
SIC: 2834 Pharmaceutical Preparations